Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 100 of 100 entries
Sorted by: Best Match Show Resources per page
Flow Cytometry: A Blessing and a Curse.

Biomedicines

Drescher H, Weiskirchen S, Weiskirchen R.
PMID: 34829841
Biomedicines. 2021 Nov 04;9(11). doi: 10.3390/biomedicines9111613.

Flow cytometry is a laser-based technology generating a scattered and a fluorescent light signal that enables rapid analysis of the size and granularity of a particle or single cell. In addition, it offers the opportunity to phenotypically characterize and...

Cite
Drescher H, Weiskirchen S, Weiskirchen R. Flow Cytometry: A Blessing and a Curse. Biomedicines. 2021;9(11)doi: 10.3390/biomedicines9111613.
Drescher, H., Weiskirchen, S., & Weiskirchen, R. (2021). Flow Cytometry: A Blessing and a Curse. Biomedicines, 9(11), . https://doi.org/10.3390/biomedicines9111613
Drescher, Hannah, et al. "Flow Cytometry: A Blessing and a Curse." Biomedicines vol. 9,11 (2021). doi: https://doi.org/10.3390/biomedicines9111613
Drescher H, Weiskirchen S, Weiskirchen R. Flow Cytometry: A Blessing and a Curse. Biomedicines. 2021 Nov 04;9(11). doi: 10.3390/biomedicines9111613. PMID: 34829841; PMCID: PMC8615642.
Copy Download .nbib Format: NLM
Role of nanotechnology behind the success of mRNA vaccines for COVID-19.

Nano today

Khurana A, Allawadhi P, Khurana I, Allwadhi S, Weiskirchen R, Banothu AK, Chhabra D, Joshi K, Bharani KK.
PMID: 33815564
Nano Today. 2021 Jun;38:101142. doi: 10.1016/j.nantod.2021.101142. Epub 2021 Mar 26.

The emergency use authorization (EUA) by the US-FDA for two mRNA-based vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) has brought hope of addressing the COVID-19 pandemic which has killed more than two million people globally. Nanotechnology has played a significant...

Cite
Khurana A, Allawadhi P, Khurana I, et al. Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 2021;38:101142doi: 10.1016/j.nantod.2021.101142.
Khurana, A., Allawadhi, P., Khurana, I., Allwadhi, S., Weiskirchen, R., Banothu, A. K., Chhabra, D., Joshi, K., & Bharani, K. K. (2021). Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano today, 38101142. https://doi.org/10.1016/j.nantod.2021.101142
Khurana, Amit, et al. "Role of nanotechnology behind the success of mRNA vaccines for COVID-19." Nano today vol. 38 (2021): 101142. doi: https://doi.org/10.1016/j.nantod.2021.101142
Khurana A, Allawadhi P, Khurana I, Allwadhi S, Weiskirchen R, Banothu AK, Chhabra D, Joshi K, Bharani KK. Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 2021 Jun;38:101142. doi: 10.1016/j.nantod.2021.101142. Epub 2021 Mar 26. PMID: 33815564; PMCID: PMC7997390.
Copy Download .nbib Format: NLM
Wilson disease - the impact of hyperimmunity on disease activity: A case report.

World journal of clinical cases

Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R.
PMID: 33644206
World J Clin Cases. 2021 Feb 26;9(6):1386-1393. doi: 10.12998/wjcc.v9.i6.1386.

BACKGROUND: In Wilson disease lack of biliary copper excretion causes hepatocellular injury by accumulation of free toxic copper. Its overspill to serum accounts for neuronal damage as second common manifestation. Therapy with copper chelators or zinc targets the removal...

Cite
Stremmel W, Longerich T, Liere R, et al. Wilson disease - the impact of hyperimmunity on disease activity: A case report. World J Clin Cases. 2021;9(6):1386-1393doi: 10.12998/wjcc.v9.i6.1386.
Stremmel, W., Longerich, T., Liere, R., Vacata, V., van Helden, J., & Weiskirchen, R. (2021). Wilson disease - the impact of hyperimmunity on disease activity: A case report. World journal of clinical cases, 9(6), 1386-1393. https://doi.org/10.12998/wjcc.v9.i6.1386
Stremmel, Wolfgang, et al. "Wilson disease - the impact of hyperimmunity on disease activity: A case report." World journal of clinical cases vol. 9,6 (2021): 1386-1393. doi: https://doi.org/10.12998/wjcc.v9.i6.1386
Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R. Wilson disease - the impact of hyperimmunity on disease activity: A case report. World J Clin Cases. 2021 Feb 26;9(6):1386-1393. doi: 10.12998/wjcc.v9.i6.1386. PMID: 33644206; PMCID: PMC7896689.
Copy Download .nbib Format: NLM
Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?.

Digestive diseases (Basel, Switzerland)

Manzhalii EG, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, Stremmel W.
PMID: 33839722
Dig Dis. 2021 Apr 09; doi: 10.1159/000516412. Epub 2021 Apr 09.

BACKGROUND: The pathophysiology of hepatic encephalopathy (HE) is incompletely understood. It remains elusive how the contributing factors of neuronal ammonia accumulation, cell swelling, and inflammation interact.OBJECTIVE: The objective of this study was to find the correlation between neuronal autoantibody...

Cite
Manzhalii EG, Falalyeyeva TM, Moyseyenko VO, et al. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?. Dig Dis. 2021;doi: 10.1159/000516412.
Manzhalii, E. G., Falalyeyeva, T. M., Moyseyenko, V. O., Weiskirchen, R., & Stremmel, W. (2021). Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?. Digestive diseases (Basel, Switzerland), . https://doi.org/10.1159/000516412
Manzhalii, Elina G, et al. "Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?." Digestive diseases (Basel, Switzerland) vol. (2021). doi: https://doi.org/10.1159/000516412
Manzhalii EG, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, Stremmel W. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?. Dig Dis. 2021 Apr 09; doi: 10.1159/000516412. Epub 2021 Apr 09. PMID: 33839722.
Copy Download .nbib Format: NLM
Showing 97 to 100 of 100 entries